Pediatric Endocrinologist (Child Hormone Specialist)
My research focuses on investigation of the etiology and possible treatment for obesity and metabolic abnormalities in individuals with Prader-Willi syndrome and early-onset obesity. I have been working towards achieving an appropriate treatment for hyperphagia for the past 12 years. I currently follow over 500 patients with Prader-Willi syndrome from around the world, and over 100 patients with early-onset obesity due to other genetic causes. I am working on clinical treatment trials to treat hyperphagia in individuals with Prader-Willi syndrome and early-onset obesity..
This is a long-term extension trial to study the safety and tolerability of continued setmelanotide treatment in patients who have completed a previous clinical trial on treatment with setmelanotide for obesity associated with genetic defects鈥�
This is a multi-center, multi-period study with an open-label period followed by a double-blind, placebo-controlled, randomized withdrawal period evaluating the safety and efficacy of DCCR treatment.
68 publications
2024
Journal of neurodevelopmental disorders
鈥�2024
Obesity (Silver Spring, Md.)
鈥�2024
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
鈥�2023
The Journal of Clinical Endocrinology & Metabolism
鈥�2023
Obesity science & practice
鈥�